According to the World Health Organization (WHO), over 422 million people globally live with diabetes, while the Institute for Health Metrics and Evaluation (IHME) reports obesity prevalence has doubled since 1990, significantly increasing demand for GLP-1 analogues for effective metabolic disorder management
In addition, Licochalcone A, a potent anti-inflammatory and antioxidant derived from licorice root, helps calm irritation, reduce redness, and protect the skin from environmental stress
In unstressed cells, the amount of GSH is ~90% compared to ~10% GSSG [11]
And these extra pounds are leading to a wide range of health issues, from diabetes to cardiovascular disease
Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery
however, all side effects were mild